Explore answers to our most commonly asked questions about CBD, our products, and more.
CJC/IPA Blend combines a GHRH analog such as CJC-1295 with Ipamorelin, a ghrelin-receptor agonist. The blend is meant to bring together two different upstream pathways involved in endogenous growth-hormone signaling. It is described as a research blend used in endocrine signaling studies.
This blend is usually studied for pulsatile growth-hormone release, GH/IGF-1 signaling, and experimental models of endocrine signaling. The exact behavior of the blend depends on whether the CJC component is DAC or non-DAC, since that changes its half-life and pulse pattern.
Subscribe to receive your promo code and occasional email updates about new research materials.
By subscribing, you agree to our Privacy and Cookie Policy and Terms & Conditions.
Our agents are here to help you.
The products on this website are for legitimate research use only. They are not intended to prevent, treat, or cure any illness or disease and are not intended for human consumption. By accessing this site, you acknowledge that you are at least 21 years of age, understand these terms, and have a legitimate research basis for buying these products.
NOTE: All of our compounds are sold individually and are supplied as research materials only. Laboratory consumables are not included, and we do not provide reconstitution, administration, or human-use instructions.
